Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor

PETAH TIKVA, Israel & BOCA RATON, Fla.–(ORGANIZATION CORD)– # 24hourABPM– Biobeat shut a $50M Collection B, led by Ally Bridge, OrbiMed, and Elevage, to increase united state commercialization of its 24 hr FDA-cleared ABPM.

发布者:Dr.Durant,转转请注明出处:https://robotalks.cn/biobeat-secures-50-million-series-b-financing-to-advance-commercialization-of-its-patch-worn-cuff-less-24-hour-ambulatory-blood-pressure-monitor/

(0)
上一篇 30 12 月, 2025
下一篇 30 12 月, 2025

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。